Jeffrey Cohen
Stock Analyst at Ladenburg Thalmann
(0.35)
# 3,978
Out of 4,818 analysts
24
Total ratings
26.67%
Success rate
-29.53%
Average return
Main Sectors:
Stocks Rated by Jeffrey Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELH Celsius Holdings | Maintains: Neutral | $62 → $58 | $37.84 | +53.28% | 3 | Mar 27, 2025 | |
| ECOR electroCore | Maintains: Buy | $28 → $26 | $6.58 | +295.14% | 2 | Mar 13, 2025 | |
| ZYXI Zynex | Downgrades: Neutral | n/a | $2.24 | - | 2 | Mar 12, 2025 | |
| NUWE Nuwellis | Downgrades: Neutral | n/a | $0.88 | - | 1 | Nov 8, 2023 | |
| SABS SAB Biotherapeutics | Downgrades: Neutral | n/a | $1.32 | - | 1 | Oct 5, 2023 | |
| CKPT Checkpoint Therapeutics | Maintains: Buy | $65 → $47 | $4.04 | +1,064.81% | 2 | Aug 15, 2023 | |
| VERO Venus Concept | Maintains: Buy | $536 → $363 | $2.60 | +13,861.54% | 2 | Mar 28, 2023 | |
| FBIO Fortress Biotech | Initiates: Buy | $90 | $1.55 | +5,706.45% | 1 | Aug 4, 2022 | |
| HROW Harrow | Initiates: Buy | $14 | $22.94 | -37.88% | 1 | Jul 2, 2021 | |
| OPK OPKO Health | Initiates: Buy | $7 | $1.43 | +391.23% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $4.98 | +944.18% | 1 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $551,250 | $1.09 | +50,573,294.50% | 1 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $4.93 | - | 1 | May 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $48.02 | - | 5 | Apr 27, 2017 |
Celsius Holdings
Mar 27, 2025
Maintains: Neutral
Price Target: $62 → $58
Current: $37.84
Upside: +53.28%
electroCore
Mar 13, 2025
Maintains: Buy
Price Target: $28 → $26
Current: $6.58
Upside: +295.14%
Zynex
Mar 12, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.24
Upside: -
Nuwellis
Nov 8, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.88
Upside: -
SAB Biotherapeutics
Oct 5, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.32
Upside: -
Checkpoint Therapeutics
Aug 15, 2023
Maintains: Buy
Price Target: $65 → $47
Current: $4.04
Upside: +1,064.81%
Venus Concept
Mar 28, 2023
Maintains: Buy
Price Target: $536 → $363
Current: $2.60
Upside: +13,861.54%
Fortress Biotech
Aug 4, 2022
Initiates: Buy
Price Target: $90
Current: $1.55
Upside: +5,706.45%
Harrow
Jul 2, 2021
Initiates: Buy
Price Target: $14
Current: $22.94
Upside: -37.88%
OPKO Health
Jun 21, 2021
Initiates: Buy
Price Target: $7
Current: $1.43
Upside: +391.23%
Apr 19, 2021
Initiates: Buy
Price Target: $52
Current: $4.98
Upside: +944.18%
Jun 26, 2020
Initiates: Buy
Price Target: $551,250
Current: $1.09
Upside: +50,573,294.50%
May 18, 2017
Upgrades: Buy
Price Target: n/a
Current: $4.93
Upside: -
Apr 27, 2017
Downgrades: Neutral
Price Target: n/a
Current: $48.02
Upside: -